Abstract Lipid‐lowering drugs produce myopathic side effects in up to 7% of treated patients, with severe rhabdomyolysis occurring in as many as 0.5%. Underlying metabolic muscle diseases have not been evaluated extensively. In a cross‐sectional study of 136 patients with drug‐induced myopathies, we...
No comments yet
Be the first to share your thoughts!